Ke Tang

9.3k citations

105 papers · 5.5k indexed · 4 hit papers · h-index 41

Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 10
- Cancer-related molecular mechanisms research 7
Immunology top 1%
- Immune Cell Function and Interaction 13
- Immune cells in cancer 13
- Immunotherapy and Immune Responses 7
Molecular Biology top 2%
- Extracellular vesicles in disease 12
- RNA Interference and Gene Delivery 8
- RNA modifications and cancer 8
Oncology top 2%
Cell Biology top 5%

Co-authors: Jingwei Ma Bo Huang Pingwei Xu Jiadi Lv Yuying Liu Huafeng Zhang Xiaoyu LiangJing Xie
Cited by: Cancer Research Immunology Molecular Biology
Journals: Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)
Partner nations: China United States Canada

In The Last Decade

Ke Tang

101 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2024 Nature Immunology
2024 Nature Cell Biology
2020 Science Immunology
2018 Nature Communications

Peers

Countries citing papers authored by Ke Tang

Since Specialization

Citations

This map shows the geographic impact of Ke Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Tang more than expected).

Fields of papers citing papers by Ke Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Tang. The network helps show where Ke Tang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ke Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ke Tang Line = papers co-authored together Ke Tang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A novel prostate cancer-specific fluorescent probe based on extracellular vesicles targeting STEAP1 applied in fluorescence guided surgery Journal of Controlled Release ·Jian‐Xuan Sun,Qi‐Dong Xia,Jin‐Zhou Xu,Ye An,Si-Yang Ma,Jingyu Xu,Jia-Cheng Xiang,Chen‐Qian Liu,Mengyao Xu,Si-Han Zhang,Yang Luan,Ke Tang,S. Wang	2025	2
2	Co‐Translational Deposition of N⁶‐Acetyl‐L‐Lysine in Nascent Proteins Contributes to the Acetylome in Mammalian Cells Advanced Science ·Dingyuan Guo,Nan Li,Xiaoyan Zhang,Runxin Zhou,Jié He,Xiaoyu Ding,Weixing Yu,Fuqiang Tong,Sibi Yin,Yu Wang,Xin Xu,Long Wang,Mingzhu Fan,Shan Feng,Ke Liu,Ke Tang,Zhuqing Ouyang,Yusong R. Guo,Yugang Wang	2024	0
3	Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG Science ·Jie Chen,Yabo Zhou,Zhuohang Liu,Yan Lü,Yishen Jiang,Kexin Cao,Nannan Zhou,Dianheng Wang,Chaoqi Zhang,Ning Zhou,Keqing Shi,Lu Zhang,Li Zhou,Zhenfeng Wang,Huafeng Zhang,Ke Tang,Jingwei Ma,Jiadi Lv,Bo Huang	2024	28
4	Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR–RUNX1 Nature Immunology ·Li Zhou,Dongxiao Wu,Yabo Zhou,Dianheng Wang,Hai‐Xia Fu,Qiu-Sha Huang,Guohui Qin,Jie Chen,Jiadi Lv,Shaoyang Lai,Huafeng Zhang,Ke Tang,Jingwei Ma,Roland Fiskesund,Yi Zhang,Xiaohui Zhang,Bo Huang	2023	20
5	TCR activation directly stimulates PYGB-dependent glycogenolysis to fuel the early recall response in CD8+ memory T cells Molecular Cell ·Huafeng Zhang,Jincheng Liu,Zhuoshun Yang,Liping Zeng,Keke Wei,Liyan Zhu,Liang Tang,Dianheng Wang,Yabo Zhou,Jiadi Lv,Nannan Zhou,Ke Tang,Jingwei Ma,Bo Huang	2022	29
6	The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release mBio ·Zhen Yuan,Bing Hu,Hurong Xiao,Xuan Tan,Yan Li,Ke Tang,Yonghui Zhang,Kun Cai,Binbin Ding	2022	45
7	Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program Cancer Research ·Ke Tang,Liyan Zhu,Jie Chen,Dianheng Wang,Liping Zeng,Chen Chen,Liang Tang,Li Zhou,Keke Wei,Yabo Zhou,Jiadi Lv,Yuying Liu,Huafeng Zhang,Jingwei Ma,Bo Huang	2021	75
8	Author Correction: The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency Nature Biomedical Engineering ·Qingle Liang,Nana Bie,Tuying Yong,Ke Tang,Xiaolong Shi,Zhaohan Wei,Haibo Jia,Xiaoqiong Zhang,Haiyan Zhao,Wei Huang,Lu Gan,Bo Huang,Xiangliang Yang	2021	2
9	Beyond energy storage: roles of glycogen metabolism in health and disease FEBS Journal ·Huafeng Zhang,Jingwei Ma,Ke Tang,Bo Huang	2020	43
10	Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells Cancer Research ·Yuying Liu,Tianzhen Zhang,Haizeng Zhang,Jiping Li,Nannan Zhou,Roland Fiskesund,Junwei Chen,Jiadi Lv,Jingwei Ma,Huafeng Zhang,Ke Tang,Feiran Cheng,Yabo Zhou,Xiaohui Zhang,Ning Wang,Bo Huang	2020	88
11	Exosomal CircGDI2 Suppresses Oral Squamous Cell Carcinoma Progression Through the Regulation of MiR-424-5p/SCAI Axis SHILAP Revista de lepidopterología ·Yong Zhang,Ke Tang,Lingxi Chen,Meng Du,Zigang Qu	2020	1
12	The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency Nature Biomedical Engineering ·Qingle Liang,Nana Bie,Tuying Yong,Ke Tang,Xiaolong Shi,Zhaohan Wei,Haibo Jia,Xiaoqiong Zhang,Haiyan Zhao,Wei Huang,Lu Gan,Bo Huang,Xiangliang Yang	2019	189
13	The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein Antiviral Research ·Xiaoyu Zhang,Ke Tang,Ying Guo	2019	24
14	Fibrin Stiffness Mediates Dormancy of Tumor-Repopulating Cells via a Cdc42-Driven Tet2 Epigenetic Program Cancer Research ·Yuying Liu,Jiadi Lv,Xiaoyu Liang,Xiaonan Yin,Le Zhang,Degao Chen,Xun Jin,Roland Fiskesund,Ke Tang,Jingwei Ma,Huafeng Zhang,Wenqian Dong,Siqi Mo,Tianzhen Zhang,Feiran Cheng,Yabo Zhou,Jing Xie,Ning Wang,Bo Huang	2018	88
15	Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells Cancer Immunology Research ·Jingwei Ma,Keke Wei,Huafeng Zhang,Ke Tang,Fei Li,Tianzhen Zhang,Junwei Liu,Pingwei Xu,Yuandong Yu,Weiwei Sun,Liyan Zhu,Jie Chen,Li Zhou,Xiaoyu Liang,Jiadi Lv,Roland Fiskesund,Yuying Liu,Bo Huang	2018	64
16	Circulating Tumor Microparticles Promote Lung Metastasis by Reprogramming Inflammatory and Mechanical Niches via a Macrophage-Dependent Pathway Cancer Immunology Research ·Huafeng Zhang,Yuandong Yu,Li Zhou,Jingwei Ma,Ke Tang,Pingwei Xu,Tiantian Ji,Xiaoyu Liang,Jiadi Lv,Wenqian Dong,Tianzhen Zhang,Degao Chen,Jing Xie,Yuying Liu,Bo Huang	2018	48
17	Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors Cancer Research ·Yong Li,Shunqun Luo,Ruihua Ma,Jing Liu,Pingwei Xu,Huafeng Zhang,Ke Tang,Jingwei Ma,Yi Zhang,Xiaoyu Liang,Yanling Sun,Tiantian Ji,Ning Wang,Bo Huang	2015	68
18	Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling Cancer Immunology Research ·Yi Zhang,Ke Tang,Ruihua Ma,Jingwei Ma,Yong Li,Shunqun Luo,Xiaoyu Liang,Tiantian Ji,Zhichao Gu,Jinzhi Lu,Wei He,Xuetao Cao,Yonghong Wan,Bo Huang	2014	125
19	Soft fibrin gels promote selection and growth of tumorigenic cells Nature Materials ·Jing Liu,Youhua Tan,Huafeng Zhang,Yi Zhang,Pingwei Xu,Junwei Chen,Yeh Chuin Poh,Ke Tang,Ning Wang,Bo Huang	2012	384
20	In silico expression analysis of human novel gene UBAP1 in multiple cancers Chinese Journal of Cancer Research ·Jun Qina,Ke Tang,Cao Li,Weifang Li,Rong Wang,Guiyuan Li	2002	1

About Ke Tang

Ke Tang is a scholar working on Immunology, Cancer Research and Biological Psychiatry, having authored 105 papers that have together received 5.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), Immune cells in cancer (13 papers), Extracellular vesicles in disease (12 papers), Cancer, Hypoxia, and Metabolism (10 papers), RNA Interference and Gene Delivery (8 papers), RNA modifications and cancer (8 papers), Immunotherapy and Immune Responses (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Immunology (1.6k citations) and Molecular Biology (2.9k citations). Ke Tang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jingwei Ma, Bo Huang, Pingwei Xu, Bo Huang, Jiadi Lv, Yuying Liu, Huafeng Zhang, Xiaoyu Liang, Huafeng Zhang and Jing Xie. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact